Order Article Reprints

Espinel W, Champine M, Hampel H, Jeter J, Sweet K, Pilarski R, Pearlman R, Shane K, Brock P, Westman JA, et al. Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients. Cancers. 2022; 14(10):2426. https://doi.org/10.3390/cancers14102426

Espinel, Whitney, Marjan Champine, Heather Hampel, Joanne Jeter, Kevin Sweet, Robert Pilarski, Rachel Pearlman, Kate Shane, Pamela Brock, Judith A. Westman, and et al. 2022. "Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients" Cancers 14, no. 10: 2426. https://doi.org/10.3390/cancers14102426

Espinel, W., Champine, M., Hampel, H., Jeter, J., Sweet, K., Pilarski, R., Pearlman, R., Shane, K., Brock, P., Westman, J. A., Kipnis, L., Sotelo, J., Chittenden, A., Culver, S., Stopfer, J. E., Schneider, K. A., Sacca, R., Koeller, D. R., Gaonkar, S., ... Esplin, E. D. (2022). Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients. Cancers, 14(10), 2426. https://doi.org/10.3390/cancers14102426